← All companies
StageSeed
Raised$1.23 million
Founded2022
Employees3
LocationNewark
About
Entirety Biomedical is working to become the standard of care in ortho fixation implants, starting with maxillofacial and extremities, to offer cosmetic trauma and reconstruction surgery patients pain-free restoration of natural function at a lower cost of care. Patent pending Curasorb metal alloy combines safe & optimal implant absorption to restore the implant site to its natural state without surgical removal of the implant. This next generation of absorbable implants are less-invasive and more sustainable than current standards of care, while maintaining the strength and cost of Titanium implants for the surgeon, translating to better outcomes over a streamlined recovery process.
Product
- Value proposition
- Cutting-edge absorbable metal implants (Curasorb Alloy) that match the performance and implantation simplicity of titanium implants, yet safely absorb after healing to eliminate lifelong concerns with permanent hardware.
- Target customers
- surgeons, patients
Founders
- Jake Edick — Co-Founder & CEO
- Carolyn Woldring — Co-Founder & CTO
Categories
Products
Curasorb Alloy absorbable implants
Key features
engineered absorbable alloymatches performance of titaniumsimple implantationtemporary implants with permanent peace of mindreduces complications and costs of permanent hardware
Technologies
Curasorb Alloyabsorbable metal implantsimplantation technology
Target conditions
cosmetic procedurestraumareconstruction
Care settings
surgeryclinichospital
Investors
NuFund Venture GroupMichigan RiseUnion Heritage VenturesRevere PartnersCommunity Equity PartnersAmerican Society of Plastic SurgeonsMass Medical Angels
News
- Entirety Biomedical Closes $1.2 Million Seed Financing to Advance Absorbable Magnesium Implants for Orthopedic Fixation - BioSpace · 2026-02-12T05:16:37.000Z
- Entirety Biomedical Closes $1.2 Million Seed Financing to Advance Absorbable Magnesium Implants for Orthopedic Fixation · 2026-02-11T00:00:00.000Z
- Entirety Biomedical Closes $1.2 Million Seed Financing to Advance Absorbable Magnesium Implants for Orthopedic Fixation - MedTech Innovator · 2026-02-11T22:04:44.000Z
- Entirety Biomedical Closes $1.2 Million Seed Financing to Advance Absorbable Magnesium Implants for Orthopedic Fixation | The Manila Times · 2026-02-11T16:11:26.000Z
- From Spreadsheets to Scalable QMS: QuickVault Customer Story · 2025-04-29T15:43:54.000Z


